Browse > Article
http://dx.doi.org/10.13045/acupunct.2016012

Snake Venom synergized Cytotoxic Effect of Natural Killer Cells on NCI H358 Human Lung Cancer Cell Growth through Induction of Apoptosis  

Oh, Jae Woo (Department of Acupuncture & Moxibustion Medicine, College of Oriental Medicine, Gachon University)
Song, Ho Sueb (Department of Acupuncture & Moxibustion Medicine, College of Oriental Medicine, Gachon University)
Publication Information
Journal of Acupuncture Research / v.33, no.2, 2016 , pp. 1-9 More about this Journal
Abstract
Objectives : I investigated whether snake venom can synergistically strengthen the cytotoxic effects of NK-92 cells, and enhance the inhibition of the growth of lung cancer cells including NCI-H358 through the induction of death receptor dependent extrinsic apoptosis. Methods : Snake venom toxin inhibited cell growth of NCI-H358 Cells and exerted non influence on NK-92 cell viability. Moreover, when they were co-cultured with NK cells and concomitantly treated with $4{\mu}g/m{\ell}$ of snake venom toxin, more influence was exerted on the inhibition of growth of NCI-H358 cells than BV or NK cell co-culture alone. Results : The expression of Fas, TNFR2 and DR3 and in NCI-H358 lung cancer cells was significantly increased by co-culture of NK-92 cells and treatment of $4{\mu}g/m{\ell}$ of snake venom toxin, compared to co-culture of NK-92 cells alone. Coincidentally, Bax, caspase-3 and caspase-8 - expressions of pro-apoptotic proteins in the extrinsic apoptosis pathway, demonstrated significant increase. However, in anti-apoptotic NF-${\kappa}B$ activities, activity of the signal molecule was significantly decreased by co-culture of NK-92 cells and treatment of $4{\mu}g/m{\ell}$ of snake venom toxin, compared to co-culture of NK-92 cells or snake venom toxin treated by NCIH358 alone. Meanwhile, in terms of NO generation, there is a significant increase, in co-culture of NK-92 cells with NCI-H358 cells as well as the co-culture of NK-92 cells and concomitant treatment of $4{\mu}g/m{\ell}$ of snake venom toxin. However, no synergistic increase of NO generation was shown in co-culture of NK-92 cells and treatment of $4{\mu}g/m{\ell}$ of snake venom toxin, compared to co-culture of NK-92 cells with NCI-H358 cells. Conclusion : Consequently, this data provides that snake venom toxin could be useful candidate compounds to suppress lung cancer growth along with the cytotoxic effect of NK-92 cells through extrinsic apoptosis.
Keywords
Snake Venom; Lung cancer; NCI-H358; NK-92; Death receptor; Nitric Oxide(NO);
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Park JH, Jeong YJ, Park KK et al. Melittin suppresses PMA-induced tumor cell invasion by inhibiting NF-kappaB and AP-1-dependent MMP-9 expression. Mol Cells. 2010 ; 29(2) : 209-15.   DOI
2 Park MH, Choi MS, Kwak DH et al. Anticancer effect of Bee Venom in prostate cancer cells through activation of caspase pathway via inactivation of NF-${\kappa}B$. Prostate. 2011 ; 71(8) : 801-12.   DOI
3 Liu S, Yu M, He Y et al. Melittin prevents liver cancer cell metastasis through inhibition of the Rac1-dependent pathway. Hepatology. 2008 ; 47(6) : 1964-73.   DOI
4 Son DJ, Park MH, Chae SJ et al. Inhibitory effect of SVT from Vipera lebetina turanica on hormone-refractory human prostate cancer cell growth : induction of apoptosis through inactivation of nuclear factor kappaB. Mol Cancer Ther. 2007 ; 6(2) : 675-83.   DOI
5 Park MH, Son DJ, Kwak DH et al. Snake venom toxin inhibits cell growth through induction of apoptosis in neuroblastoma cells. Arch Pharm Res. 2009 ; 32(11) : 1545-54.   DOI
6 Takeo S, Yasumoto K, Nagashima A, Nakahashi H, Sugimachi K, Nomoto K. Role of tumor-associated macrophages in lung cancer. Cancer Res. 1986 ; 46(6) : 3179-82.
7 Takanami I, Takeuchi K, Giga M. The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thorac Cardiovasc Surg. 2001 ; 121(6) : 1058-63.   DOI
8 Villegas FR, Coca S, Villarrubia VG et al. Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung Cancer. 2002 ; 35(1) : 23-8.   DOI
9 Rusch V, Klimstra D, Venkatraman E et al. Aberrant p53 expression predicts clinical resistance to cisplatin-based chemotherapy in locally advanced nonsmall cell lung cancer. Cancer Res. 1995 ; 55(21) : 5038-42.
10 Swann JB, Smyth MJ. Immune surveillance of tumors. J Clin Invest. 2007 ; 117(5) : 1137-46.   DOI
11 Kim JH, Song HS. Bee Venom Enhanced Cytotoxic Effect of Natural Killer Cells on Human Lung Cancer Through Inducing Extrinsic Apoptosis. The Acupuncture. 2014 ; 31(1) : 111-9.
12 Wiley SR, Schooley K, Smolak PJ et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity. 1995 ; 3(6) : 673-82.   DOI
13 Ashkenazi A, Pai RC, Fong S et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest. 1999 ; 104(2) : 155-62.   DOI
14 Walczak H, Miller RE, Ariail K et al. Tumoricidal activity of tumor necrosis factor-related apoptosis inducing ligand in vivo. Nat Med. 1999 ; 5(2) : 157-63.   DOI
15 Ljunggren HG, Malmberg KJ. Prospects for the use of NK cells in Immuno-therapy of human cancer. Nat Rev Immunol. 2007 ; 7(5) : 329-39.   DOI
16 Sabry M, Lowdell MW. Tumor-primed NK cells : waiting for the green light. Front Immunology. 2013 ; 4 : 408.
17 Nagata S. Apoptosis by death factor. Cell. 1997 ; 88(3) : 355-65.   DOI
18 Walczak H, Krammer PH. The CD95 (APO-1/Fas) and the TRAIL(APO-2L) apoptosis systems. Exp Cell Res. 2000 ; 256(1) : 58-66.   DOI
19 Jones DR, Broad DR, Madrid LV, Baldwin AS, Mayo MW. Inhibition of NF-${\kappa}B$ sensitizes nonsmall cell lung cancer cells to chemotherapy induced apoptosis. Ann Thorac Surg. 2000 ; 70(3) : 930-7.   DOI
20 Havell EA, Fiers W, North RJ. The antitumor function of tumor necrosis factor (TNF). I. Therapeutic action of TNF against an established murine sarcoma is indirect, immunologically dependent, and limited by severe toxicity. J Exp Med. 1988 ; 167(3) : 1067-85.   DOI
21 Jones DR, Broad RM, Comeau LD, Parsons SJ, Mayo MW. Inhibition of nuclear factor B chemosensitizes non-small cell lung cancer through cytochrome c release and caspase activation. J Thorac Cardiovasc Surg. 2002 ; 123(2) : 310-7.   DOI
22 Singh RP, Malikarjuna GU, Sharma G et al. Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor ${\kappa}B$-mediated inducible chemoresistance. Clin Cancer Res. 2004 ; 10(24) : 8641-7.   DOI
23 Burris HA. Shortcomings of current therapies for non-small-cell lung cancer : unmet medical needs. Oncogene. 2009 ; 28(Suppl. 1) : S4-S13.   DOI
24 Jung KW, Won YJ, Kong HJ et al. Cancer statistics in Korea : incidence, mortality, survival, and prevalence in 2012. Cancer Res Treat. 2015 ; 47(2) : 127-41.   DOI
25 Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011 ; 61(4) : 212-36.   DOI
26 Mayo MW, Denlinger CE, Broad RM et al. Ineffectiveness of histone deacetylase inhibitors to induce apoptosis involves the transcriptional activation of NF-kappa B through the Akt pathway. J Biol Chem. 2003 ; 278(21) : 18980-9.   DOI
27 Henkart PA. Lymphocyte-mediated cytotoxicity : two pathways and multiple effector molecules. Immunity. 1994 ; 1(15) : 343-6.   DOI
28 Kojima H, Shinohara N, Hanaoka S et al. Two distinct pathways of specific killing revealed by perforin mutant cytotoxic T lymphocytes. Immunity. 1994 ; 1(5) : 357-64.   DOI
29 Cifone MG, Ulisse S, Santoni A. Natural killer cells and Nitric Oxide. Int Immunopharmacol. 2001 ; 1(8) : 1513-24.   DOI
30 Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC. Cigarette smoking and subsequent risk of lung cancer in men and women : analysis of a prospective cohort study. Lancet Oncol. 2008 ; 9(7) : 649–56.   DOI
31 Benlloch S, Galbis-Caravajal JM, Alenda C et al. Expression of molecular markers in mediastinal nodes from resected stage I non-smallcell lung cancer (NSCLC) : prognostic impact and potential role as markers of occult micrometastases. Ann. Oncol. 2009 ; 20(1) : 91-7.   DOI
32 Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer : epidemiology, risk factors, treatment, and survivorship. Mayo Clin. Proc. 2008 ; 83(5) : 584-94.   DOI
33 Giaccone G. Clinical perspectives on platinum resistance. Drugs. 2000 ; 59 suppl 4 : 9-17.
34 Schiller JH, Larson T, Ou SH et al. Efficacy and safety of axitinib in patients with advanced non-small-cell lung cancer : results from a phase II study. J Clin Oncol. 2009 ; 27(23) : 3836-41.   DOI
35 Park HJ, Lee SH, Son DJ et al. Antiarthritic effect of Bee Venom : inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum. 2004 ; 50(11) : 3504-15.   DOI